A Precision Oncology Micro-Organosphere-Based Platform to Guide Multiple Myeloma Therapy
Research Grant
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Xilis, Inc.
Start Date
August 1, 2022
End Date
September 30, 2023
Administered By
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Xilis, Inc.
Start Date
August 1, 2022
End Date
September 30, 2023